4591 - 4600 of 6295 Results
Title
Year
-
OPENTitle: Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.838674Best OA location URL: https://doi.org/10.3389/fnagi.2022.838674Citation Count: 5
-
OPENTitle: Interactome Screening Identifies the ER Luminal Chaperone Hsp47 as a Regulator of the Unfolded Protein Response Transducer IRE1αJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 2Start Page: 238End Page: 252.e7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2017.12.028Best OA location URL: https://repositorio.uchile.cl/handle/2250/150446Citation Count: 154
-
OPENTitle: Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brainJournal Name: Current Research in Pharmacology and Drug DiscoveryPublisher: Elsevier BVVol: 1Issue #:Start Page: 19End Page: 29Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.crphar.2020.04.001Best OA location URL: https://doi.org/10.1016/j.crphar.2020.04.001Citation Count: 11
-
OPENTitle: LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived NeuronsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00442Best OA location URL: https://doi.org/10.3389/fnins.2020.00442Citation Count: 44
-
OPENTitle: Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 32Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1073/pnas.2402206121Best OA location URL: https://doi.org/10.1073/pnas.2402206121Citation Count: 16
-
OPENTitle: Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomesJournal Name: Current BiologyPublisher: Elsevier BVVol: 31Issue #: 10Start Page: 2140End Page: 2154.e6Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cub.2021.02.061Best OA location URL: http://www.cell.com/article/S0960982221003055/pdfCitation Count: 146
-
OPENTitle: Mapping cerebral blood perfusion and its links to multi-scale brain organization across the human lifespanJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 23Issue #: 7Start Page: e3003277End Page: e3003277Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3003277Best OA location URL: https://doi.org/10.1371/journal.pbio.3003277Citation Count: 0
-
OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Best OA location URL: https://doi.org/10.1186/s12883-024-03702-3Citation Count: 5
-
OPENTitle: Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine modelJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 149Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-025-02859-6Best OA location URL: https://doi.org/10.1007/s00401-025-02859-6Citation Count: 1
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://escholarship.org/uc/item/8jf94062Citation Count: 9